Correlation Between Israel China and Palram

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Israel China and Palram at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Israel China and Palram into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Israel China Biotechnology and Palram, you can compare the effects of market volatilities on Israel China and Palram and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Israel China with a short position of Palram. Check out your portfolio center. Please also check ongoing floating volatility patterns of Israel China and Palram.

Diversification Opportunities for Israel China and Palram

-0.77
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Israel and Palram is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Israel China Biotechnology and Palram in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Palram and Israel China is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Israel China Biotechnology are associated (or correlated) with Palram. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Palram has no effect on the direction of Israel China i.e., Israel China and Palram go up and down completely randomly.

Pair Corralation between Israel China and Palram

Assuming the 90 days trading horizon Israel China Biotechnology is expected to under-perform the Palram. In addition to that, Israel China is 2.19 times more volatile than Palram. It trades about -0.06 of its total potential returns per unit of risk. Palram is currently generating about 0.24 per unit of volatility. If you would invest  483,478  in Palram on August 28, 2024 and sell it today you would earn a total of  259,922  from holding Palram or generate 53.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Israel China Biotechnology  vs.  Palram

 Performance 
       Timeline  
Israel China Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Israel China Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental drivers, Israel China is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Palram 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Palram are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Palram sustained solid returns over the last few months and may actually be approaching a breakup point.

Israel China and Palram Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Israel China and Palram

The main advantage of trading using opposite Israel China and Palram positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Israel China position performs unexpectedly, Palram can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Palram will offset losses from the drop in Palram's long position.
The idea behind Israel China Biotechnology and Palram pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Global Correlations
Find global opportunities by holding instruments from different markets